Human menopausal gonadotropin-induced bioprosthetic valve thrombosis

Rami Mahmood Abazid; Mohamed Shoman; Osama A Smettie; Osama A Elamin

doi:10.4103/ajm.AJM_83_18

Human menopausal gonadotropin-induced bioprosthetic valve thrombosis

Avicenna J Med. 2018 Jul-Sep;8(3):114-116. doi: 10.4103/ajm.AJM_83_18.

Authors

Rami Mahmood Abazid¹, Mohamed Shoman¹, Osama A Smettie¹, Osama A Elamin¹

Affiliation

¹ Department of Cardiology, Prince Sultan Cardiac Center Qassim, King Fahad Specialist Hospital, Buraydah, Al-Qassim Province, Saudi Arabia.

Abstract

Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 39-year-old female, who underwent redo mitral valve replacement. To the best of our knowledge, this is the first case of hMG-induced BPVT in a young female patient.

Keywords: Bioprosthetic valve thrombosis; human menopausal gonadotropin; in vitro fertilization.

Publication types

Case Reports